Sign Out
Use in pregnancy: Pregnancy Category C: There are no adequate and well-controlled studies of ipratropium bromide or salbutamol sulphate in pregnant women. Ipralin HFA inhaler should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Use in lactation: It is not known whether the components of Ipralin HFA inhaler are excreted in human milk. Ipralin HFA inhaler should not be used by breastfeeding mothers, unless the expected benefit is thought to outweigh the risks.
